OneSource Specialty Pharma Surges 17.77%: 2 Key Drivers Behind the Rally

1 hour ago
share
Share Via
OneSource Specialty Pharma Ltd delivered a remarkable weekly performance, surging 17.77% from Rs.1,540.35 to Rs.1,814.05 between 20 and 24 April 2026. This strong rally notably outpaced the Sensex, which declined 1.31% over the same period, underscoring the stock’s robust momentum amid mixed market conditions and sectoral headwinds.

Key Events This Week

20 Apr: Stock opens at Rs.1,547.85 with modest gains despite Sensex dip

21 Apr: High-value trading with 29.54 lakh shares and ₹45,262 lakh turnover

22 Apr: Price jumps 3.19% amid volatile market

23 Apr: Intraday high of Rs.1,718.9 with 9.78% daily gain

24 Apr: Week closes at Rs.1,814.05, up 2.58% on the day

Week Open
Rs.1,540.35
Week Close
Rs.1,814.05
+17.77%
Week High
Rs.1,814.05
vs Sensex
+19.08%

Monday, 20 April 2026: Modest Start Amid Market Weakness

OneSource Specialty Pharma Ltd began the week on a positive note, closing at Rs.1,547.85, up 0.49% from the previous Friday’s close of Rs.1,540.35. This gain came despite the Sensex slipping marginally by 0.02% to 35,814.68. The stock’s resilience in a broadly flat market set the tone for the week’s upward trajectory, supported by steady volume of 9,909 shares.

Tuesday, 21 April 2026: High-Value Trading Highlights Investor Interest

The stock witnessed exceptional trading activity on Tuesday, with a volume of 1,346,646 shares and a turnover exceeding ₹45,262 lakh, making it one of the most actively traded stocks by value in the Pharmaceuticals & Biotechnology sector. Despite this, the price closed slightly lower at Rs.1,561.05, a 0.43% dip from the previous day’s close, reflecting some profit-taking amid strong sectoral gains and a 0.77% rise in the Sensex to 36,091.30.

Technical analysis showed the stock trading above its 5-day, 20-day, 50-day, and 100-day moving averages, signalling short- to medium-term strength, although it remained below the 200-day average. Institutional delivery volumes declined by 29.13% compared to the 5-day average, suggesting cautious participation despite robust liquidity.

This week's disclosed pick, a Large Cap from NBFC, comes with precise Target Price and analysis. Check if you're positioned right for this opportunity!

  • - Precise target price set
  • - Weekly selection live
  • - Position check opportunity

Check Your Position →

Wednesday, 22 April 2026: Price Gains Amid Volatility

On Wednesday, the stock rebounded strongly, climbing 3.19% to close at Rs.1,610.90. This gain contrasted with a 0.23% decline in the Sensex to 36,009.59, highlighting the stock’s relative strength. The volume of 25,076 shares indicated moderate trading activity as investors responded positively to the stock’s technical positioning and recent trading patterns.

Thursday, 23 April 2026: Intraday High and Significant Surge

OneSource Specialty Pharma Ltd delivered its most impressive performance on Thursday, surging 9.78% to close at Rs.1,768.40. During the session, the stock hit an intraday high of Rs.1,718.9, marking a 7.44% rise from the previous close. This rally was achieved despite a broadly negative market, with the Sensex falling 0.78% to 35,729.71.

The stock outperformed its Pharmaceuticals & Biotechnology sector by 4.5%, supported by strong technical indicators including trading above all key moving averages (5-day through 200-day). This marked the fifth consecutive day of gains, accumulating a 13.74% return over this period. The Mojo Score upgrade to ‘Sell’ from ‘Strong Sell’ earlier in April may have contributed to renewed investor confidence.

Considering OneSource Specialty Pharma Ltd? Wait! SwitchER has found potentially better options in and beyond. Compare this small-cap with top-rated alternatives now!

  • - Better options discovered
  • - + beyond scope
  • - Top-rated alternatives ready

Compare & Switch Now →

Friday, 24 April 2026: Week Closes Strong

The stock maintained its upward momentum on Friday, gaining 2.58% to close at Rs.1,814.05, the highest price of the week. This final push came amid a continued decline in the Sensex, which fell 1.06% to 35,349.66. The volume of 76,311 shares reflected sustained investor interest, capping a week of strong gains and technical outperformance.

Date Stock Price Day Change Sensex Day Change
2026-04-20 Rs.1,547.85 +0.49% 35,814.68 -0.02%
2026-04-21 Rs.1,561.05 +0.85% 36,091.30 +0.77%
2026-04-22 Rs.1,610.90 +3.19% 36,009.59 -0.23%
2026-04-23 Rs.1,768.40 +9.78% 35,729.71 -0.78%
2026-04-24 Rs.1,814.05 +2.58% 35,349.66 -1.06%

Key Takeaways

Strong Weekly Outperformance: The stock’s 17.77% weekly gain sharply contrasts with the Sensex’s 1.31% decline, highlighting significant relative strength and investor appetite for OneSource Specialty Pharma Ltd.

Robust Trading Volumes and Liquidity: Exceptional turnover on 21 April with over ₹45,262 lakh traded indicates strong market interest and liquidity, supporting sizeable trades without major price impact.

Technical Strength and Momentum: Trading above all major moving averages by week’s end signals a robust upward trend, reinforced by positive technical indicators such as MACD and Bollinger Bands on weekly charts.

Mojo Score Upgrade: The upgrade from ‘Strong Sell’ to ‘Sell’ on 13 April 2026 suggests a cautious improvement in outlook, which may have contributed to the sustained buying momentum during the week.

Cautionary Signals: Despite strong gains, the stock remains a small-cap with some volatility risk. The decline in institutional delivery volumes on 21 April and the broader market weakness warrant continued vigilance.

Conclusion

OneSource Specialty Pharma Ltd’s performance in the week ending 24 April 2026 was marked by a powerful rally driven by high-value trading, technical resilience, and a modest upgrade in market sentiment. The stock’s ability to outperform the Sensex and its sector amid a challenging market environment underscores its current strength. However, investors should remain mindful of the stock’s small-cap status and mixed signals from institutional participation. Overall, the week’s developments reflect a nuanced but positive phase for OneSource Specialty Pharma Ltd, with momentum favouring the bulls for now.

{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News